Results 171 to 180 of about 3,775 (204)

Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection

Clinical Microbiology and Infection, 2021
Cynthia L Gong, Matthew M Hitchcock, Marisa Holubar   +2 more
exaly  

Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes

Infection, 2021
Rosa Escudero-Sánchez, Antonio Ramos-Martínez, Javier Cobo   +2 more
exaly  

Fidaxomicin

Reactions Weekly, 2018
openaire   +2 more sources

Fidaxomicin

Reactions Weekly, 2023
openaire   +1 more source

Rivaroxaban, ticagrelor, and fidaxomicin

Journal of the American Pharmacists Association, 2011
Daniel A, Hussar, Amanda F, Schartel
openaire   +2 more sources

Fidaxomicin

Reactions Weekly, 2014
openaire   +1 more source

Fidaxomicin/vancomycin

Reactions Weekly, 2021
openaire   +1 more source

Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection

Antibiotics, 2023
Laura Whitney, John Nesnas, Tim Planche   +2 more
exaly  

Fidaxomicin

2022
openaire   +1 more source

Fidaxomicin forClostridium difficileInfection

New England Journal of Medicine, 2011
Amy, Linsky, Kalpana, Gupta, John A, Hermos   +2 more
openaire   +3 more sources